Lymphoma Archives - Oncology Nurse Advisor

A Prospective Study on Urine Alkalization With an Oral Regimen Consisting of Sodium Bicarbonate and Acetazolamide in Patients Receiving High-dose Methotrexate

October 11, 2019

[Cancer Management and Research] Researchers sought an alternative regimen for urine alkalization in patients receiving high-dose methotrexate. The typical regimen, IV sodium bicarbonate, has been on shortage. This study determined the safety of an oral regimen of sodium bicarbonate and acetazolamide to achieve a urine pH >7, which is necessary for safe administration of high-dose methotrexate.

Coloured scanning electron micrograph (SEM) of cancellous (spongy) bone.

Leukemia

Factors Predict Low BMD in Pediatric Blood Cancer Survivors

October 8, 2019

Low bone mineral density detected during guideline-recommended dual-energy X-ray absorptiometry.

A doctor and patient discuss medical files.

Lymphoma

Tailored Monitoring May Be Warranted in Patients With Diffuse Large B-Cell Lymphoma

By

Sonali Gattani

October 2, 2019

The development of secondary primary malignancies in patients with diffuse large B-cell lymphoma varies in accordance with several risk factors.

Recent and upcoming case reports suggest possible cases of gluteal and other implant-associated ALCLs, raising questions about the cancer risk across all types of implants.

Hematologic Cancers

Implant-Associated Cancers: A Look Beyond BIA-ALCL

By

Bryant Furlow

October 1, 2019

Recent and upcoming case reports suggest possible cases of gluteal and other implant-associated ALCLs, raising questions about the cancer risk across all types of implants.

A family discusses fertility options with a clinician.

Lymphoma

Parents of Children With Cancer Benefit From a Novel Resilience Intervention: Results From the PRISM-P Trial

By

Susan Moench, PhD, PA-C

October 1, 2019

Results of the PRISM-P trial compared the benefits parents of children with cancer derived from resilience training in a 1-on-1 setting vs group setting vs usual psychosocial care alone.

A patient undergoes regular chemotherapy.

ESMO 2019

Retrovirally Naïve HIV+ Patients With Non-Hodgkin Lymphoma Can Be Treated With Standard Chemotherapy

By

Tiffany Garbutt, PhD

September 30, 2019

Researchers investigated the efficacy and safety of CHOP-like therapy for treatment-naïve patients with simultaneous diagnoses of NHL and HIV-positive.

Current treatment strategies for immune thrombocytopenic purpura are centered on immunomodulation and decreasing platelet destruction

Lymphoma

Improving the Clinical Diagnosis and Classification of Gray Zone Lymphomas

By

Caleb Rans

September 26, 2019

Although gray zone lymphoma has distinct morphologic features, immunophenotyping can make classifying gray zone lymphoma challenging.

Publishers Alliance

Primary Spinal Epidural Diffuse Large B-cell Lymphoma With Paraplegia as the First Manifestation: A Case Report

September 20, 2019

[OncoTargets and Therapy] In this patient case, after 2 misdiagnoses and surgery, a diagnosis of spinal epidural DLBCL was made and the patient was treated with 6 cycles of R-CHOPE. The authors explain when to suspect PSEL in patients with spinal cord compression.

Oncologists are changing the way they treat, perhaps too quickly and with too little evidence — but the behavior may signal a bigger problem with how research is reported.

Lymphoma

Use of Single Tool Insufficient for Measuring Health-Related Quality of Life in Patients With Cutaneous T-Cell Lymphoma

By

Megan Garlapow, PhD

September 17, 2019

Researchers determined that several validated assessment tools are needed to measure health-related quality of life in patients with cutaneous T-cell lymphoma.

Lymphoma

Incidence of GI Adverse Events Associated With CAR-T Therapy for Lymphoma or Leukemia Is Low

By

Susan Moench, PhD, PA-C

September 10, 2019

A retrospective evaluation of patients with leukemia or lymphoma treated with CAR-T therapy determined their likelihood of experiencing refractory colitis associated with the treatment.